Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy R Marks

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Digestive Diseases and Sciences|January 4, 2017
Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer TissueTheodore R Levin, Douglas A Corley, Christopher D Jensen, et al.
The American Journal of Medicine|November 25, 2015
Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease StatusVincent Lo Re, Dean M Carbonari, James D Lewis, et al.
Gastrointestinal Endoscopy|August 26, 2018
Index colonoscopy-related risk factors for postcolonoscopy colorectal cancersTheodore A Tollivoro, Christopher D Jensen, Amy R Marks, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2015
Validity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure eventsVincent Lo Re, Dena M Carbonari, Kimberly A Forde, et al.
Gastroenterology|March 4, 2015
Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care systemDavid S Goldberg, Kimberly A Forde, Dean M Carbonari, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based settingChristopher D Jensen, Chyke A Doubeni, Virginia P Quinn, et al.
The New England Journal of Medicine|April 4, 2014
Adenoma detection rate and risk of colorectal cancer and deathDouglas A Corley, Christopher D Jensen, Amy R Marks, et al.
Gastroenterology|May 17, 2022
Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based PopulationJeffrey K Lee, Angela Y Lam, Christopher D Jensen, et al.
JAMA|April 27, 2017
Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at DiagnosisDouglas A Corley, Christopher D Jensen, Virginia P Quinn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2015
Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic ModelVincent Lo Re, Kevin Haynes, Kimberly A Forde, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Digestive Diseases and Sciences|January 4, 2017
Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer TissueTheodore R Levin, Douglas A Corley, Christopher D Jensen, et al.
The American Journal of Medicine|November 25, 2015
Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease StatusVincent Lo Re, Dean M Carbonari, James D Lewis, et al.
Gastrointestinal Endoscopy|August 26, 2018
Index colonoscopy-related risk factors for postcolonoscopy colorectal cancersTheodore A Tollivoro, Christopher D Jensen, Amy R Marks, et al.
Pharmacoepidemiology and Drug Safety|April 14, 2015
Validity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure eventsVincent Lo Re, Dena M Carbonari, Kimberly A Forde, et al.
Gastroenterology|March 4, 2015
Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care systemDavid S Goldberg, Kimberly A Forde, Dean M Carbonari, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based settingChristopher D Jensen, Chyke A Doubeni, Virginia P Quinn, et al.
The New England Journal of Medicine|April 4, 2014
Adenoma detection rate and risk of colorectal cancer and deathDouglas A Corley, Christopher D Jensen, Amy R Marks, et al.
Gastroenterology|May 17, 2022
Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based PopulationJeffrey K Lee, Angela Y Lam, Christopher D Jensen, et al.
JAMA|April 27, 2017
Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at DiagnosisDouglas A Corley, Christopher D Jensen, Virginia P Quinn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2015
Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic ModelVincent Lo Re, Kevin Haynes, Kimberly A Forde, et al.
Pageof 4